alt text alt text


Accelerating the development of safe and effective treatments for children and adolescents

Leverage our deep understanding of the diverse populations—spanning preterm infants to adolescents—to guide your pediatric research.

Address the needs of pediatric patients and their families across your development journey with our extensive regulatory, medical and operational expertise.

Speed up your pediatric drug development plan with our best practices to efficiently enroll adolescents and young adult populations into your pivotal trials.

Pediatric patients and their families are at the center of all we do.

Participating in a pediatric trial requires a huge commitment not just from a patient, but also their family. That’s why our pediatric experts at Fortrea work to develop tailored solutions that address specific study considerations, minimize the burden of the participation and support successful study conduct.

At Fortrea, we share your passion to make a difference in patients’ lives. You’ll get a partner that:

  • Understands the nuances of pediatric research
  • Offers longstanding experience designing, planning and conducting pediatric programs
  • Delivers the collective knowledge of 34 pediatricians and more than 2,400 employees experienced with pediatric populations

Together, let’s address the inherent challenges of pediatric studies and navigate the best path ahead. 

Experience matters when choosing a partner.

In the last 5 years

Across all phases of development, many indications and all pediatric age groups, we’ve been honored to serve as a CRO partner of choice for our biotech and pharmaceutical customers.


Pediatric projects in total


Rare disease projects involving pediatric populations


Advanced therapy projects (including cell and gene therapy) involving pediatric populations

Our top therapeutic areas for pediatrics include:

We’re committed to bringing clinical research to all.

As your partner, we can work as an extension of your team and:

  • Develop and execute your pediatric regulatory strategy and provide consulting to support your PIP and iPSP
  • Provide pediatric program development and study design including protocol writing
  • Enable custom strategy and planning for your program including feasibility, optimal country and site selection
  • Create relevant patient and family facing materials including assent/ consent for the different pediatric age groups
  • Collaborate with relevant advocacy groups, such as the International Children’s Advisory Network (iCAN)

Serving as your agile partner for complex and novel clinical trials

Let our multidisciplinary experts put their experience to work to advance your pediatric drug development program and transform obstacles into opportunities. Together, we’ll improve your potential for success and make a difference in urgent unmet medical needs.

Explore our related areas of expertise. 


세포 및 유전자 치료 Rare Diseases Our Team (RAPT)

최신 소식 받기:
Fortrea 뉴스 및 공지사항을 구독하세요.